Welch Capital Partners LLC NY Sells 6,395 Shares of Humana Inc. (NYSE:HUM)

by · The Cerbat Gem

Welch Capital Partners LLC NY decreased its stake in Humana Inc. (NYSE:HUM – Free Report) by 23.2% during the 1st quarter, Holdings Channel reports. The firm owned 21,203 shares of the insurance provider’s stock after selling 6,395 shares during the quarter. Humana makes up approximately 1.3% of Welch Capital Partners LLC NY’s investment portfolio, making the stock its 9th largest position. Welch Capital Partners LLC NY’s holdings in Humana were worth $5,610,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also modified their holdings of HUM. Cary Street Partners Investment Advisory LLC boosted its position in Humana by 63.9% during the first quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock worth $31,000 after acquiring an additional 46 shares during the last quarter. Applied Finance Capital Management LLC boosted its position in Humana by 1.7% during the first quarter. Applied Finance Capital Management LLC now owns 2,943 shares of the insurance provider’s stock worth $779,000 after acquiring an additional 48 shares during the last quarter. Achmea Investment Management B.V. boosted its position in Humana by 0.5% during the first quarter. Achmea Investment Management B.V. now owns 10,379 shares of the insurance provider’s stock worth $2,746,000 after acquiring an additional 49 shares during the last quarter. Beech Hill Advisors Inc. boosted its position in Humana by 6.1% during the first quarter. Beech Hill Advisors Inc. now owns 865 shares of the insurance provider’s stock worth $229,000 after acquiring an additional 50 shares during the last quarter. Finally, Deseret Mutual Benefit Administrators boosted its position in Humana by 15.8% during the first quarter. Deseret Mutual Benefit Administrators now owns 462 shares of the insurance provider’s stock worth $122,000 after acquiring an additional 63 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the stock. Mizuho boosted their price target on shares of Humana from $305.00 to $316.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 9th. Wall Street Zen lowered shares of Humana from a “buy” rating to a “hold” rating in a report on Saturday. Piper Sandler decreased their target price on shares of Humana from $288.00 to $272.00 and set a “neutral” rating on the stock in a report on Thursday, July 31st. Truist Financial decreased their target price on shares of Humana from $280.00 to $260.00 and set a “hold” rating on the stock in a report on Wednesday, July 16th. Finally, Bank of America decreased their target price on shares of Humana from $320.00 to $260.00 and set a “neutral” rating on the stock in a report on Tuesday, June 17th. Seventeen analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $281.62.

View Our Latest Report on HUM

Humana Price Performance

Humana stock opened at $254.95 on Wednesday. The company’s 50 day simple moving average is $236.10 and its 200-day simple moving average is $254.67. The company has a market capitalization of $30.66 billion, a price-to-earnings ratio of 19.57, a price-to-earnings-growth ratio of 1.45 and a beta of 0.44. Humana Inc. has a 1 year low of $206.87 and a 1 year high of $382.72. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95.

Humana (NYSE:HUM – Get Free Report) last announced its earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing the consensus estimate of $6.32 by ($0.05). Humana had a return on equity of 13.67% and a net margin of 1.28%. The business had revenue of $32.39 billion for the quarter, compared to analysts’ expectations of $31.85 billion. During the same period in the previous year, the company earned $6.96 earnings per share. Humana’s quarterly revenue was up 9.6% on a year-over-year basis. As a group, equities research analysts expect that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Profile

(Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Further Reading

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).